Oyagbemi, Ademola AdetokunboOmobowale, Temidayo OlutayoAdejumobi, Olumuyiwa AbiolaOwolabi, Abiodun MaryOgunpolu, Blessing SeunFalayi, Olufunke OlubunmiHassan, Fasilat OluwakemiOgunmiluyi, Iyanuoluwa OmololaAsenuga, Ebunoluwa RachealOla-Davies, Olufunke EuniceSoetan, Kehinde OlugboyegaSaba, Adebowale BenardAdedapo, Adeolu AlexNkadimeng, Sanah MalomileMcGaw, Lyndy JoyOguntibeju, Oluwafemi OmoniyiYakubu, Momoh Audu2023-10-312023-10-312020-08Oyagbemi, A.A., Omobowale, T.O., Adejumobi, O.A. et al. 2020, 'Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway', European Journal of Pharmacology, vol. 880, art. 173142, pp. 1-13, doi : 10.1016/j.ejphar.2020.173142.0014-2999 (print)1879-0712 (online)10.1016/j.ejphar.2020.173142http://hdl.handle.net/2263/93122Please read abstract in the article.en© 2020 Elsevier B.V. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in European Journal of Pharmacology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in European Journal of Pharmacology, vol. 880, art. 173142, pp. 1-13, doi : 10.1016/j.ejphar.2020.173142.Hypertension (HTN)Oxidative stressNaringeninNovel-antihypertensive agentSDG-03: Good health and well-beingAntihypertensive powerMineralocorticoid receptor (MCR)Angiotensin converting enzyme (ACE)Kidney injury molecule (Kim-1)Postprint Article